{"title":"Effect Of Omega-3 Fatty Acids On Cardiovascular Protection- A Randomised Controlled Clinical Interventional Study","authors":"Rukaiah Fatma Begum, M. Sumithra, R. Velmurugan","doi":"10.47750/pnr.2022.13.s08.592","DOIUrl":null,"url":null,"abstract":"There is a great deal of public belief in the cardiovascular benefits of omega-3 fats. Recent trials of omega-3 fatty acids in cardiovascular issues are unclear or failed to show the significant benefit for reducing cardiovascular events. To perform a human trial of omega 3 fatty acids supplementation to test its effectiveness on cardiovascular diseases. A randomized interventional study was carried out in 145 patients in the age group of 18 or older at any risk of cardiovascular disease. Treatment period of 6 months with supplementation of daily dose of 360 mg of EPA and 480 mg of DHA for one group and to the other group, atorvastatin 10 mg was given. Biochemical and clinical evaluation was performed for the baseline, 3rd and the 6th months to assess the effectiveness of omega 3 fatty acids on cardiovascular diseases. The changes in the biochemical parameters total cholesterol, HDL, LDL and triglycerides among the omega 3 fatty acid group and statin group were as 218.17 vs 204.45, 55.24 vs 60.3, 142.9 vs 132.41and 168.95 vs 152.5 respectively with a p value of 0.0001. Omega 3 supplements have little or no effect on the risk of cardiovascular diseases according to the research. The better evidence identified in this research does not demonstrate any cardiovascular protection with the supplementation of omega 3 fats.","PeriodicalId":16728,"journal":{"name":"Journal of Pharmaceutical Negative Results","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Negative Results","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47750/pnr.2022.13.s08.592","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
There is a great deal of public belief in the cardiovascular benefits of omega-3 fats. Recent trials of omega-3 fatty acids in cardiovascular issues are unclear or failed to show the significant benefit for reducing cardiovascular events. To perform a human trial of omega 3 fatty acids supplementation to test its effectiveness on cardiovascular diseases. A randomized interventional study was carried out in 145 patients in the age group of 18 or older at any risk of cardiovascular disease. Treatment period of 6 months with supplementation of daily dose of 360 mg of EPA and 480 mg of DHA for one group and to the other group, atorvastatin 10 mg was given. Biochemical and clinical evaluation was performed for the baseline, 3rd and the 6th months to assess the effectiveness of omega 3 fatty acids on cardiovascular diseases. The changes in the biochemical parameters total cholesterol, HDL, LDL and triglycerides among the omega 3 fatty acid group and statin group were as 218.17 vs 204.45, 55.24 vs 60.3, 142.9 vs 132.41and 168.95 vs 152.5 respectively with a p value of 0.0001. Omega 3 supplements have little or no effect on the risk of cardiovascular diseases according to the research. The better evidence identified in this research does not demonstrate any cardiovascular protection with the supplementation of omega 3 fats.
公众对ω-3脂肪对心血管的益处深信不疑。最近关于ω-3脂肪酸治疗心血管疾病的试验尚不清楚或未能显示其对减少心血管事件的显著益处。进行一项补充ω3脂肪酸的人体试验,以测试其对心血管疾病的有效性。对145名年龄在18岁或以上、有心血管疾病风险的患者进行了随机干预研究。治疗期为6个月,其中一组每日补充360 mg EPA和480 mg DHA,另一组每天补充10 mg阿托伐他汀。在基线、第3个月和第6个月进行生化和临床评估,以评估ω-3脂肪酸对心血管疾病的有效性。ω3脂肪酸组和他汀类药物组的总胆固醇、高密度脂蛋白、低密度脂蛋白和甘油三酯的生化参数变化分别为218.17 vs 204.45、55.24 vs 60.3、142.9 vs 132.41和168.95 vs 152.5,p值为0.0001。研究表明,欧米茄3补充剂对心血管疾病的风险几乎没有影响。这项研究中发现的更好的证据并没有证明补充ω3脂肪对心血管有任何保护作用。